Exparel Injectable Product
PRO17060305
Phase 3 small_molecule completed
Quick answer
Exparel Injectable Product for Coronary Artery Disease is a Phase 3 program (small_molecule) at Pacira BioSciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pacira BioSciences
- Indication
- Coronary Artery Disease
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed